Xenetic Biosciences (XBIO)
(Delayed Data from NSDQ)
$3.99 USD
+0.15 (3.79%)
Updated Sep 13, 2024 03:17 PM ET
3-Hold of 5 3
C Value C Growth F Momentum D VGM
Cash flow Statements
Fiscal Year End for Xenetic Biosciences, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -4.13 | -6.55 | -5.65 | -10.89 | -12.78 |
Depreciation/Amortization & Depletion | 0.00 | 0.03 | 0.04 | 9.27 | 3.31 |
Net Change from Assets/Liabilities | -0.26 | -0.43 | 0.46 | -0.05 | -0.88 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 0.28 | 2.31 | 0.41 | -2.59 | 3.95 |
Net Cash From Operating Activities | -4.11 | -4.65 | -4.74 | -4.27 | -6.40 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -0.50 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.00 | -0.50 | 0.00 | 0.00 | 0.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 11.45 | 5.43 | 16.13 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.00 | 0.00 | 11.45 | 5.43 | 16.13 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -4.11 | -5.15 | 6.72 | 1.16 | 9.73 |
Cash at Beginning of Period | 13.10 | 18.24 | 11.53 | 10.37 | 0.64 |
Cash at End of Period | 8.98 | 13.10 | 18.24 | 11.53 | 10.37 |
Diluted Net EPS | -2.71 | -4.60 | -5.50 | -17.00 | -63.30 |
Fiscal Year End for Xenetic Biosciences, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -2.47 | -1.20 | -4.13 | -2.96 | -1.91 |
Depreciation/Amortization & Depletion | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change from Assets/Liabilities | 0.67 | -0.04 | -0.26 | -0.57 | -0.60 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 0.12 | 0.08 | 0.28 | 0.21 | 0.14 |
Net Cash From Operating Activities | -1.68 | -1.16 | -4.11 | -3.32 | -2.37 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -1.68 | -1.16 | -4.11 | -3.32 | -2.37 |
Cash at Beginning of Period | 8.98 | 8.98 | 13.10 | 13.10 | 13.10 |
Cash at End of Period | 7.30 | 7.82 | 8.98 | 9.78 | 10.73 |
Diluted Net EPS | -0.83 | -0.78 | -0.73 | -0.69 | -0.69 |